The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Epidermal growth factor-induced nuclear factor κB activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells
Open accessAbstract
The epidermal growth factor (EGF) family of receptors (EGFR) is overproduced in estrogen receptor (ER) negative (−) breast cancer cells. An inverse correlation of the level of EGFR and ER is observed between ER− and ER positive (+) breast cancer cells. A comparative study with EGFR-overproducing ER− and low-level producing ER+ breast cancer cells suggests that EGF is a major growth-stimulating factor for ER− cells. An outline of the pathway for the EGF-induced enhanced proliferation of ER− human breast cancer cells is proposed. The transmission of mitogenic signal induced by EGF–EGFR interaction is mediated via activation of nuclear factor κB (NF-κB). The basal level of active NF-κB in ER− cells is elevated by EGF and inhibited by anti-EGFR antibody (EGFR-Ab), thus qualifying EGF as a NF-κB activation factor. NF-κB transactivates the cell-cycle regulatory protein, cyclin D1, which causes increased phosphorylation of retinoblastoma protein, more strongly in ER− cells. An inhibitor of phosphatidylinositol 3 kinase, Ly294–002, blocked this event, suggesting a role of the former in the activation of NF-κB by EGF. Go6976, a well-characterized NF-κB inhibitor, blocked EGF-induced NF-κB activation and up-regulation of cell-cycle regulatory proteins. This low molecular weight compound also caused apoptotic death, predominantly more in ER− cells. Thus Go6976 and similar NF-κB inhibitors are potentially novel low molecular weight therapeutic agents for treatment of ER− breast cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
Self-citationSelective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976
Martiny-Baron, G., Kazanietz, M. G., Mischak, H., Blumberg, P. M., Kochs, G., Hug, H., Marmé, D., & Schächtele, C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98335-3 · Cited by 1,565
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
A Restriction Point for Control of Normal Animal Cell Proliferation
Pardee, A. B. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.4.1286 · Cited by 1,415
Self-citationNF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
Mechanisms and consequences of activation of protein kinase B/Akt
Downward, J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80149-x · Cited by 1,303
The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
Kumar, V., & Chambon, P. (1988) · Cell · doi:10.1016/0092-8674(88)90017-7 · Cited by 1,220
Constitutive Activation of NF-κB during Progression of Breast Cancer to Hormone-Independent Growth
Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J., & Sledge, G. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3629 · Cited by 819
Hinz, M., Krappmann, D., Eichten, A., Heder, A., Scheidereit, C., & Strauss, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.4.2690 · Cited by 788
Hortobagyi, G. N. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391407 · Cited by 781
Hunter, T. (1997) · Cell · doi:10.1016/s0092-8674(00)81872-3 · Cited by 550
Steroid receptors and their associated proteins
Smith, D. F. (1993) · Molecular Endocrinology · doi:10.1210/me.7.1.4 · Cited by 545
Finco, T. S., Westwick, J. K., Norris, J. L., Beg, A. A., Der, C. J., & Baldwin, A. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.39.24113 · Cited by 375
Rodrigues, G. A., Falasca, M., Zhang, Z., Ong, S. H., & Schlessinger, J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1448-1459.2000 · Cited by 345
La Rosa, F. A., Pierce, J. W., & Sonenshein, G. E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1039 · Cited by 283
Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.
Duyao, M. P., Buckler, A. J., & Sonenshein, G. E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4727 · Cited by 278
HTLV-I Tax Protein Binds to MEKK1 to Stimulate IκB Kinase Activity and NF-κB Activation
Yin, M.-J., Christerson, L. B., Yamamoto, Y., Kwak, Y.-T., Xu, S., Mercurio, F., Barbosa, M., Cobb, M. H., & Gaynor, R. B. (1998) · Cell · doi:10.1016/s0092-8674(00)81447-6 · Cited by 262
Her-2/neu as a Predictive Marker of Response to Breast Cancer Therapy
Pegram, M. D., Pauletti, G., & Slamon, D. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006111117877 · Cited by 259
Tsai, S. Y., Tsai, M.-J., & O'Malley, B. W. (1989) · Cell · doi:10.1016/0092-8674(89)90919-7 · Cited by 255
Band, V, & Sager, R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.4.1249 · Cited by 194
Newby, J. C., Johnston, S. R. D., Smith, I. E., et al. (1997) · PubMed · Cited by 192
Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts.
Baldwin, A. S., Azizkhan, J. C., Jensen, D. E., Beg, A. A., & Coodly, L. R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.4943 · Cited by 162
Unrestricted cell cycling and cancer
Strauss, M., Lukas, J., & Bartek, J. (1995) · Nature Medicine · doi:10.1038/nm1295-1245 · Cited by 158
Jordan, V. C. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00713399 · Cited by 150
Chemiluminescence in analytical chemistry
Isacsson, U., & Wettermark, G. (1974) · Analytica Chimica Acta · doi:10.1016/s0003-2670(01)82590-3 · Cited by 135
Sun, L., & Carpenter, G. F. (1998) · Oncogene · doi:10.1038/sj.onc.1201731 · Cited by 129
Galang, C. K., Garcı́a-Ramı́rez, J. J., Solski, P. A., Westwick, J. K., Der, C. J., Neznanov, N. S., Oshima, R. G., & Hauser, C. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.14.7992 · Cited by 127
Ras - a versatile cellular switch
Rommel, C., & Hafen, E. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80111-1 · Cited by 101
Role of PI 3-kinase in mitogenesis
Varticovski, L., Harrison-Findik, D. D., Keeler, M. L., & Šuša, M. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(94)90051-5 · Cited by 98
Obata, H., Biro, S., Arima, N., Kaieda, H., Kihara, T., Eto, H., Miyata, M., & Tanaka, H. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0979 · Cited by 84
The strategic use of antiestrogens to control the development and growth of breast cancer.
Jordan, V. C. (1992) · PubMed · Cited by 77
Ram, T. G., & Ethier, S. P. (1996) · PubMed · Cited by 73
Anti-inflammatory properties of Gö 6850: a selective inhibitor of protein kinase C.
Jacobson, P. B., Kuchera, S. L., Metz, A., Schächtele, C., Imre, K., & Schrier, D. J. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12155-1 · Cited by 71
Gekeler, V., Boer, R., Ise, W., Sanders, K. H., Schächtele, C., & Beck, J. F. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1017 · Cited by 64
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients
Placido, S. D., Carlomagno, C., Laurentiis, M. D., et al. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1006159001039 · Cited by 55
A New Interpretation of Antiestrogen Actiona
Hedden, A., Müller, V., & Jensen, E. V. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb31373.x · Cited by 51
Biswas, D. K., Salas, T., Wang, F., Ahlers, C. M., Dezube, B. J., & Pardee, A. B. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7437-7444.1995 · Cited by 51
Self-citationDeFazio, A., Chiew, Y.-E., McEvoy, M., Watts, C. K. W., & Sutherland, R. L. (1997) · PubMed · Cited by 41
Musgrove, E. A., Šarčević, B., & Sutherland, R. L. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960301)60:3<363::aid-jcb8>3.0.co;2-u · Cited by 40
Estrogen Receptor Molecular Biology
Brown, M. A. (1994) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30189-8 · Cited by 36
Cited by
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Epidermal growth factor receptor (EGFR) signaling in cancer
Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M. R., Carotenuto, A., De Feo, G., Caponigro, F., & Salomon, D. S. (2006) · Gene · doi:10.1016/j.gene.2005.10.018 · Cited by 2,038
Aggarwal, B. B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.003 · Cited by 1,574
Aggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 795
Prenzel, N., Fischer, O. M., Streit, S., Hart, S., & Ullrich, A. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080011 · Cited by 673
Metadata
- Authors
- Biswas, D. K., Cruz, A. P., Gansberger, E., & Pardee, A. B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-07-18
- Volume
- 97
- Issue
- 15
- Pages
- 8542-8547
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2026863172
- Cited by
- 351
- References
- 45
- FWCI
- 8.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.